nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—Crohn's disease	0.264	1	CbGaD
Bumetanide—PTGS2—Balsalazide—Crohn's disease	0.16	0.306	CbGbCtD
Bumetanide—PTGS2—Mesalazine—Crohn's disease	0.128	0.245	CbGbCtD
Bumetanide—SLC22A8—Mercaptopurine—Crohn's disease	0.0932	0.178	CbGbCtD
Bumetanide—PTGS2—Sulfasalazine—Crohn's disease	0.0715	0.137	CbGbCtD
Bumetanide—SLCO1A2—Prednisone—Crohn's disease	0.0698	0.134	CbGbCtD
Bumetanide—SLC10A1—bile—Crohn's disease	0.0136	0.216	CbGeAlD
Bumetanide—Serum amylase increased—Mesalazine—Crohn's disease	0.0112	0.157	CcSEcCtD
Bumetanide—CFTR—gall bladder—Crohn's disease	0.00456	0.0723	CbGeAlD
Bumetanide—CFTR—mouth—Crohn's disease	0.00406	0.0643	CbGeAlD
Bumetanide—CA9—gall bladder—Crohn's disease	0.00395	0.0625	CbGeAlD
Bumetanide—SLC12A2—mouth—Crohn's disease	0.00356	0.0564	CbGeAlD
Bumetanide—Cholestasis—Mercaptopurine—Crohn's disease	0.00286	0.04	CcSEcCtD
Bumetanide—SLC12A4—mammalian vulva—Crohn's disease	0.00261	0.0413	CbGeAlD
Bumetanide—Furosemide—SLC22A5—Crohn's disease	0.0026	0.588	CrCbGaD
Bumetanide—Liver injury—Mercaptopurine—Crohn's disease	0.00258	0.0361	CcSEcCtD
Bumetanide—Amylase increased—Mesalazine—Crohn's disease	0.00247	0.0346	CcSEcCtD
Bumetanide—CFTR—epithelium—Crohn's disease	0.00236	0.0374	CbGeAlD
Bumetanide—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00234	0.0327	CcSEcCtD
Bumetanide—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00221	0.0309	CcSEcCtD
Bumetanide—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00217	0.0304	CcSEcCtD
Bumetanide—SLC12A2—epithelium—Crohn's disease	0.00207	0.0328	CbGeAlD
Bumetanide—SLC12A2—mammalian vulva—Crohn's disease	0.0018	0.0285	CbGeAlD
Bumetanide—Upset stomach—Mesalazine—Crohn's disease	0.0018	0.0252	CcSEcCtD
Bumetanide—CFTR—digestive system—Crohn's disease	0.0018	0.0284	CbGeAlD
Bumetanide—CA7—digestive system—Crohn's disease	0.00177	0.028	CbGeAlD
Bumetanide—SLC12A1—epithelium—Crohn's disease	0.00174	0.0275	CbGeAlD
Bumetanide—Cholestasis—Azathioprine—Crohn's disease	0.0017	0.0238	CcSEcCtD
Bumetanide—SLC12A2—digestive system—Crohn's disease	0.00158	0.025	CbGeAlD
Bumetanide—CA9—digestive system—Crohn's disease	0.00155	0.0246	CbGeAlD
Bumetanide—Cholestasis—Mesalazine—Crohn's disease	0.00155	0.0217	CcSEcCtD
Bumetanide—Liver injury—Azathioprine—Crohn's disease	0.00154	0.0215	CcSEcCtD
Bumetanide—SLC10A1—digestive system—Crohn's disease	0.00149	0.0236	CbGeAlD
Bumetanide—Blood disorder—Mesalazine—Crohn's disease	0.00141	0.0197	CcSEcCtD
Bumetanide—Liver injury—Mesalazine—Crohn's disease	0.0014	0.0196	CcSEcCtD
Bumetanide—SLC22A11—digestive system—Crohn's disease	0.00136	0.0216	CbGeAlD
Bumetanide—Pancreatitis—Mercaptopurine—Crohn's disease	0.00133	0.0187	CcSEcCtD
Bumetanide—SLC22A7—digestive system—Crohn's disease	0.00133	0.021	CbGeAlD
Bumetanide—SLC12A4—lymph node—Crohn's disease	0.00131	0.0207	CbGeAlD
Bumetanide—Hepatocellular injury—Azathioprine—Crohn's disease	0.00129	0.0181	CcSEcCtD
Bumetanide—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00119	0.0167	CcSEcCtD
Bumetanide—Hepatocellular injury—Mesalazine—Crohn's disease	0.00118	0.0165	CcSEcCtD
Bumetanide—CA5B—mammalian vulva—Crohn's disease	0.00118	0.0186	CbGeAlD
Bumetanide—CA12—digestive system—Crohn's disease	0.00115	0.0182	CbGeAlD
Bumetanide—PTGS2—gall bladder—Crohn's disease	0.00111	0.0175	CbGeAlD
Bumetanide—PTGS2—mouth—Crohn's disease	0.000984	0.0156	CbGeAlD
Bumetanide—SLC12A2—lymph node—Crohn's disease	0.000901	0.0143	CbGeAlD
Bumetanide—Leukopenia—Mercaptopurine—Crohn's disease	0.000849	0.0119	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000845	0.0118	CcSEcCtD
Bumetanide—Arthralgia—Mercaptopurine—Crohn's disease	0.000807	0.0113	CcSEcCtD
Bumetanide—SLCO1A2—digestive system—Crohn's disease	0.000804	0.0127	CbGeAlD
Bumetanide—Blood creatinine increased—Mesalazine—Crohn's disease	0.0008	0.0112	CcSEcCtD
Bumetanide—Pancreatitis—Azathioprine—Crohn's disease	0.000795	0.0111	CcSEcCtD
Bumetanide—Abdominal discomfort—Azathioprine—Crohn's disease	0.000777	0.0109	CcSEcCtD
Bumetanide—Cramp muscle—Mesalazine—Crohn's disease	0.000769	0.0108	CcSEcCtD
Bumetanide—Glycosuria—Prednisone—Crohn's disease	0.000769	0.0108	CcSEcCtD
Bumetanide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000758	0.0106	CcSEcCtD
Bumetanide—Pancreatitis—Mesalazine—Crohn's disease	0.000724	0.0101	CcSEcCtD
Bumetanide—Furosemide—ALB—Crohn's disease	0.00072	0.163	CrCbGaD
Bumetanide—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000717	0.01	CcSEcCtD
Bumetanide—CA4—digestive system—Crohn's disease	0.000711	0.0113	CbGeAlD
Bumetanide—Abdominal discomfort—Mesalazine—Crohn's disease	0.000708	0.00991	CcSEcCtD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000659	0.00889	CbGpPWpGaD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000659	0.00889	CbGpPWpGaD
Bumetanide—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000653	0.00914	CcSEcCtD
Bumetanide—Renal failure—Mesalazine—Crohn's disease	0.000647	0.00906	CcSEcCtD
Bumetanide—Sweating—Mesalazine—Crohn's disease	0.000631	0.00884	CcSEcCtD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000618	0.00834	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000618	0.00834	CbGpPWpGaD
Bumetanide—Erythema multiforme—Azathioprine—Crohn's disease	0.000614	0.00859	CcSEcCtD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000598	0.00807	CbGpPWpGaD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000598	0.00807	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000595	0.00803	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000589	0.00795	CbGpPWpGaD
Bumetanide—CA5B—lymph node—Crohn's disease	0.000589	0.00932	CbGeAlD
Bumetanide—Fenoprofen—PTGS2—Crohn's disease	0.00058	0.131	CrCbGaD
Bumetanide—PTGS2—epithelium—Crohn's disease	0.000572	0.00907	CbGeAlD
Bumetanide—SLCO1A2—Transport of organic anions—ALB—Crohn's disease	0.000571	0.00771	CbGpPWpGaD
Bumetanide—Erythema multiforme—Mesalazine—Crohn's disease	0.000559	0.00783	CcSEcCtD
Bumetanide—PTGS2—smooth muscle tissue—Crohn's disease	0.000552	0.00873	CbGeAlD
Bumetanide—PTGS2—skin of body—Crohn's disease	0.000544	0.00862	CbGeAlD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000539	0.00727	CbGpPWpGaD
Bumetanide—Diarrhoea—Mercaptopurine—Crohn's disease	0.000529	0.00741	CcSEcCtD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000526	0.00709	CbGpPWpGaD
Bumetanide—Fenoprofen—ALB—Crohn's disease	0.000517	0.117	CrCbGaD
Bumetanide—Leukopenia—Azathioprine—Crohn's disease	0.000506	0.00708	CcSEcCtD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000505	0.00681	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000505	0.00681	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000505	0.00681	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000505	0.00681	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000505	0.00681	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000505	0.00681	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000503	0.00678	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000503	0.00678	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000502	0.00677	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000502	0.00677	CbGpPWpGaD
Bumetanide—Muscle spasms—Mesalazine—Crohn's disease	0.000495	0.00693	CcSEcCtD
Bumetanide—Vomiting—Mercaptopurine—Crohn's disease	0.000492	0.00689	CcSEcCtD
Bumetanide—Rash—Mercaptopurine—Crohn's disease	0.000488	0.00683	CcSEcCtD
Bumetanide—Dermatitis—Mercaptopurine—Crohn's disease	0.000487	0.00683	CcSEcCtD
Bumetanide—Arthralgia—Azathioprine—Crohn's disease	0.000481	0.00673	CcSEcCtD
Bumetanide—Vertigo—Mesalazine—Crohn's disease	0.000462	0.00647	CcSEcCtD
Bumetanide—Leukopenia—Mesalazine—Crohn's disease	0.000461	0.00645	CcSEcCtD
Bumetanide—Nausea—Mercaptopurine—Crohn's disease	0.00046	0.00644	CcSEcCtD
Bumetanide—Thrombocytopenia—Azathioprine—Crohn's disease	0.000451	0.00632	CcSEcCtD
Bumetanide—SLC10A1—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00045	0.00607	CbGpPWpGaD
Bumetanide—PTGS2—lymphoid tissue—Crohn's disease	0.000441	0.00698	CbGeAlD
Bumetanide—Arthralgia—Mesalazine—Crohn's disease	0.000438	0.00613	CcSEcCtD
Bumetanide—Chest pain—Mesalazine—Crohn's disease	0.000438	0.00613	CcSEcCtD
Bumetanide—PTGS2—digestive system—Crohn's disease	0.000436	0.0069	CbGeAlD
Bumetanide—Hypotension—Azathioprine—Crohn's disease	0.000431	0.00603	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000429	0.00579	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000429	0.00579	CbGpPWpGaD
Bumetanide—Dry mouth—Mesalazine—Crohn's disease	0.000428	0.006	CcSEcCtD
Bumetanide—SLCO1A2—Recycling of bile acids and salts—ALB—Crohn's disease	0.000423	0.00571	CbGpPWpGaD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00042	0.00566	CbGpPWpGaD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00042	0.00566	CbGpPWpGaD
Bumetanide—Hypokalaemia—Prednisone—Crohn's disease	0.000411	0.00576	CcSEcCtD
Bumetanide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000411	0.00576	CcSEcCtD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000411	0.00554	CbGpPWpGaD
Bumetanide—CA4—lymph node—Crohn's disease	0.000406	0.00643	CbGeAlD
Bumetanide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000406	0.00568	CcSEcCtD
Bumetanide—Hypotension—Mesalazine—Crohn's disease	0.000392	0.00549	CcSEcCtD
Bumetanide—Pancreatitis—Prednisone—Crohn's disease	0.000383	0.00536	CcSEcCtD
Bumetanide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000377	0.00528	CcSEcCtD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000373	0.00503	CbGpPWpGaD
Bumetanide—Abdominal pain—Azathioprine—Crohn's disease	0.000364	0.0051	CcSEcCtD
Bumetanide—Fatigue—Mesalazine—Crohn's disease	0.000362	0.00507	CcSEcCtD
Bumetanide—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000358	0.00483	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000355	0.0048	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000355	0.0048	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000355	0.0048	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000354	0.00477	CbGpPWpGaD
Bumetanide—Hyperglycaemia—Prednisone—Crohn's disease	0.000352	0.00494	CcSEcCtD
Bumetanide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000343	0.00481	CcSEcCtD
Bumetanide—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000334	0.00451	CbGpPWpGaD
Bumetanide—Urticaria—Mesalazine—Crohn's disease	0.000334	0.00467	CcSEcCtD
Bumetanide—Abdominal pain—Mesalazine—Crohn's disease	0.000332	0.00465	CcSEcCtD
Bumetanide—CA9—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000319	0.0043	CbGpPWpGaD
Bumetanide—Diarrhoea—Azathioprine—Crohn's disease	0.000315	0.00442	CcSEcCtD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000314	0.00424	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000314	0.00424	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000314	0.00424	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	0.000314	0.00423	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000313	0.00422	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000313	0.00422	CbGpPWpGaD
Bumetanide—Dizziness—Azathioprine—Crohn's disease	0.000305	0.00427	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000302	0.00408	CbGpPWpGaD
Bumetanide—Asthenia—Mesalazine—Crohn's disease	0.000301	0.00422	CcSEcCtD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.0003	0.00404	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.0003	0.00404	CbGpPWpGaD
Bumetanide—Pruritus—Mesalazine—Crohn's disease	0.000297	0.00416	CcSEcCtD
Bumetanide—Vomiting—Azathioprine—Crohn's disease	0.000293	0.0041	CcSEcCtD
Bumetanide—Rash—Azathioprine—Crohn's disease	0.000291	0.00407	CcSEcCtD
Bumetanide—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	0.000291	0.00392	CbGpPWpGaD
Bumetanide—Dermatitis—Azathioprine—Crohn's disease	0.00029	0.00407	CcSEcCtD
Bumetanide—Headache—Azathioprine—Crohn's disease	0.000289	0.00404	CcSEcCtD
Bumetanide—Diarrhoea—Mesalazine—Crohn's disease	0.000287	0.00402	CcSEcCtD
Bumetanide—Dizziness—Mesalazine—Crohn's disease	0.000278	0.00389	CcSEcCtD
Bumetanide—Nausea—Azathioprine—Crohn's disease	0.000274	0.00383	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000272	0.00367	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000272	0.00367	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000267	0.00361	CbGpPWpGaD
Bumetanide—Vomiting—Mesalazine—Crohn's disease	0.000267	0.00374	CcSEcCtD
Bumetanide—Rash—Mesalazine—Crohn's disease	0.000265	0.00371	CcSEcCtD
Bumetanide—Dermatitis—Mesalazine—Crohn's disease	0.000265	0.0037	CcSEcCtD
Bumetanide—Headache—Mesalazine—Crohn's disease	0.000263	0.00368	CcSEcCtD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000261	0.00353	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000259	0.0035	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000255	0.00344	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000255	0.00344	CbGpPWpGaD
Bumetanide—Nausea—Mesalazine—Crohn's disease	0.000249	0.00349	CcSEcCtD
Bumetanide—PTGS2—lymph node—Crohn's disease	0.000249	0.00394	CbGeAlD
Bumetanide—Vertigo—Prednisone—Crohn's disease	0.000245	0.00342	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—Crohn's disease	0.000232	0.00325	CcSEcCtD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000228	0.00308	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000228	0.00308	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000223	0.003	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000223	0.003	CbGpPWpGaD
Bumetanide—SLCO1A2—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000221	0.00298	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00022	0.00297	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	0.00022	0.00296	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Prednisone—Crohn's disease	0.000215	0.00301	CcSEcCtD
Bumetanide—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000213	0.00287	CbGpPWpGaD
Bumetanide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000212	0.00286	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000211	0.00285	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000203	0.00274	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000203	0.00274	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	0.000203	0.00274	CbGpPWpGaD
Bumetanide—Fatigue—Prednisone—Crohn's disease	0.000192	0.00268	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000192	0.00258	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000191	0.00257	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000191	0.00257	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000189	0.00255	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000189	0.00255	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000187	0.00252	CbGpPWpGaD
Bumetanide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000182	0.00254	CcSEcCtD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00018	0.00243	CbGpPWpGaD
Bumetanide—Urticaria—Prednisone—Crohn's disease	0.000177	0.00247	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—Crohn's disease	0.000176	0.00246	CcSEcCtD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000172	0.00232	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000171	0.00231	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000169	0.00228	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	0.000168	0.00227	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—RBX1—Crohn's disease	0.000168	0.00226	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—HSPA1B—Crohn's disease	0.000168	0.00226	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PLA2G4F—Crohn's disease	0.000164	0.00221	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	0.000162	0.00219	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000161	0.00217	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000161	0.00217	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PLA2G4F—Crohn's disease	0.00016	0.00215	CbGpPWpGaD
Bumetanide—Asthenia—Prednisone—Crohn's disease	0.000159	0.00223	CcSEcCtD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000159	0.00214	CbGpPWpGaD
Bumetanide—Pruritus—Prednisone—Crohn's disease	0.000157	0.0022	CcSEcCtD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000152	0.00205	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000152	0.00205	CbGpPWpGaD
Bumetanide—Diarrhoea—Prednisone—Crohn's disease	0.000152	0.00213	CcSEcCtD
Bumetanide—CA5B—Metabolism—PLA2G4F—Crohn's disease	0.000149	0.00201	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PLA2G4F—Crohn's disease	0.000149	0.00201	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—UBE2D1—Crohn's disease	0.000147	0.00198	CbGpPWpGaD
Bumetanide—Dizziness—Prednisone—Crohn's disease	0.000147	0.00206	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	0.000145	0.00196	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000143	0.00193	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000142	0.00192	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	0.000142	0.00192	CbGpPWpGaD
Bumetanide—Vomiting—Prednisone—Crohn's disease	0.000141	0.00198	CcSEcCtD
Bumetanide—Rash—Prednisone—Crohn's disease	0.00014	0.00196	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—Crohn's disease	0.00014	0.00196	CcSEcCtD
Bumetanide—CA14—Metabolism—MTMR3—Crohn's disease	0.000139	0.00188	CbGpPWpGaD
Bumetanide—Headache—Prednisone—Crohn's disease	0.000139	0.00195	CcSEcCtD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000138	0.00186	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000138	0.00186	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PLA2G4F—Crohn's disease	0.000138	0.00186	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—MTMR3—Crohn's disease	0.000136	0.00183	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000134	0.00181	CbGpPWpGaD
Bumetanide—Nausea—Prednisone—Crohn's disease	0.000132	0.00185	CcSEcCtD
Bumetanide—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	0.000132	0.00178	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000127	0.00172	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	0.000127	0.00171	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—MTMR3—Crohn's disease	0.000127	0.00171	CbGpPWpGaD
Bumetanide—CA7—Metabolism—MTMR3—Crohn's disease	0.000127	0.00171	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000126	0.0017	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000119	0.0016	CbGpPWpGaD
Bumetanide—CA12—Metabolism—MTMR3—Crohn's disease	0.000117	0.00158	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000116	0.00157	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000116	0.00157	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PLA2G4F—Crohn's disease	0.000115	0.00156	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000113	0.00153	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000113	0.00153	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000113	0.00153	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000113	0.00152	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PLA2G4F—Crohn's disease	0.00011	0.00149	CbGpPWpGaD
Bumetanide—CA14—Metabolism—FADS1—Crohn's disease	0.000109	0.00146	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000108	0.00146	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000107	0.00145	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	0.000106	0.00143	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—FADS1—Crohn's disease	0.000106	0.00143	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000103	0.00139	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000103	0.00139	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GPX4—Crohn's disease	0.000102	0.00137	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GPX4—Crohn's disease	9.9e-05	0.00134	CbGpPWpGaD
Bumetanide—CA7—Metabolism—FADS1—Crohn's disease	9.87e-05	0.00133	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—FADS1—Crohn's disease	9.87e-05	0.00133	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MTMR3—Crohn's disease	9.81e-05	0.00132	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GCKR—Crohn's disease	9.81e-05	0.00132	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.73e-05	0.00131	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.69e-05	0.00131	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.69e-05	0.00131	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ALB—Crohn's disease	9.62e-05	0.0013	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GCKR—Crohn's disease	9.56e-05	0.00129	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.48e-05	0.00128	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	9.37e-05	0.00126	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MTMR3—Crohn's disease	9.36e-05	0.00126	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GPX4—Crohn's disease	9.24e-05	0.00125	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GPX4—Crohn's disease	9.24e-05	0.00125	CbGpPWpGaD
Bumetanide—CA12—Metabolism—FADS1—Crohn's disease	9.14e-05	0.00123	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GCKR—Crohn's disease	8.93e-05	0.0012	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GCKR—Crohn's disease	8.93e-05	0.0012	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PLA2G4F—Crohn's disease	8.9e-05	0.0012	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	8.72e-05	0.00118	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.6e-05	0.00116	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GPX4—Crohn's disease	8.56e-05	0.00116	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	8.53e-05	0.00115	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.45e-05	0.00114	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GCKR—Crohn's disease	8.27e-05	0.00112	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.18e-05	0.0011	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.91e-05	0.00107	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	7.84e-05	0.00106	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.7e-05	0.00104	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—FADS1—Crohn's disease	7.64e-05	0.00103	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTMR3—Crohn's disease	7.56e-05	0.00102	CbGpPWpGaD
Bumetanide—CA4—Metabolism—FADS1—Crohn's disease	7.29e-05	0.000984	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.26e-05	0.00098	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.23e-05	0.000976	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GPX4—Crohn's disease	7.16e-05	0.000966	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	6.94e-05	0.000937	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GCKR—Crohn's disease	6.91e-05	0.000933	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GPX4—Crohn's disease	6.83e-05	0.000921	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.83e-05	0.000921	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.72e-05	0.000906	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GCKR—Crohn's disease	6.6e-05	0.00089	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.55e-05	0.000883	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	6.53e-05	0.000882	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	6.49e-05	0.000875	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	6.46e-05	0.000872	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.42e-05	0.000866	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	6.2e-05	0.000836	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.09e-05	0.000822	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	6.07e-05	0.000819	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.03e-05	0.000814	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	5.98e-05	0.000807	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CXCL8—Crohn's disease	5.97e-05	0.000806	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	5.96e-05	0.000805	CbGpPWpGaD
Bumetanide—CA9—Metabolism—FADS1—Crohn's disease	5.89e-05	0.000795	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.72e-05	0.000772	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PLA2G4F—Crohn's disease	5.68e-05	0.000766	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPX4—Crohn's disease	5.52e-05	0.000745	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GCKR—Crohn's disease	5.33e-05	0.000719	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	5.32e-05	0.000718	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.12e-05	0.000691	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.1e-05	0.000688	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.94e-05	0.000667	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTMR3—Crohn's disease	4.83e-05	0.000651	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—STAT3—Crohn's disease	4.8e-05	0.000648	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.78e-05	0.000644	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	4.72e-05	0.000636	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.55e-05	0.000614	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	4.38e-05	0.000592	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.32e-05	0.000583	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.28e-05	0.000577	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	4.21e-05	0.000568	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	3.86e-05	0.000521	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—FADS1—Crohn's disease	3.76e-05	0.000508	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RSPO3—Crohn's disease	3.58e-05	0.000483	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPX4—Crohn's disease	3.52e-05	0.000475	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLA2G4F—Crohn's disease	3.43e-05	0.000463	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	3.41e-05	0.000461	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GCKR—Crohn's disease	3.4e-05	0.000459	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SEL1L—Crohn's disease	3.39e-05	0.000458	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—Crohn's disease	3.36e-05	0.000453	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—Crohn's disease	3.12e-05	0.000421	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	3.11e-05	0.00042	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	3.1e-05	0.000418	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	3.05e-05	0.000412	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—Crohn's disease	3.04e-05	0.000411	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LTF—Crohn's disease	3.04e-05	0.000411	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTMR3—Crohn's disease	2.92e-05	0.000393	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—Crohn's disease	2.84e-05	0.000383	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—Crohn's disease	2.84e-05	0.000383	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—Crohn's disease	2.73e-05	0.000369	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—Crohn's disease	2.66e-05	0.000359	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—Crohn's disease	2.63e-05	0.000355	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	2.6e-05	0.000351	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—Crohn's disease	2.49e-05	0.000335	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—Crohn's disease	2.49e-05	0.000335	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	2.46e-05	0.000332	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GCKR—Crohn's disease	2.45e-05	0.000331	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.43e-05	0.000328	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.31e-05	0.000312	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—Crohn's disease	2.3e-05	0.000311	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FADS1—Crohn's disease	2.27e-05	0.000306	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—Crohn's disease	2.2e-05	0.000297	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	2.17e-05	0.000293	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC11A1—Crohn's disease	2.17e-05	0.000293	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPX4—Crohn's disease	2.13e-05	0.000287	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.13e-05	0.000287	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—Crohn's disease	2.1e-05	0.000283	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.08e-05	0.00028	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCKR—Crohn's disease	2.05e-05	0.000277	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—Crohn's disease	1.92e-05	0.00026	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RBX1—Crohn's disease	1.86e-05	0.000251	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HSPA1B—Crohn's disease	1.86e-05	0.000251	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—Crohn's disease	1.84e-05	0.000248	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—Crohn's disease	1.7e-05	0.000229	CbGpPWpGaD
Bumetanide—PTGS2—Disease—UBE2D1—Crohn's disease	1.63e-05	0.00022	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—Crohn's disease	1.48e-05	0.0002	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.47e-05	0.000198	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SMAD3—Crohn's disease	1.17e-05	0.000157	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—Crohn's disease	1.08e-05	0.000146	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—Crohn's disease	9.47e-06	0.000128	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TYK2—Crohn's disease	7.61e-06	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JAK2—Crohn's disease	7.26e-06	9.79e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—Crohn's disease	6.88e-06	9.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—Crohn's disease	6.54e-06	8.82e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—Crohn's disease	5.33e-06	7.19e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—Crohn's disease	3.72e-06	5.02e-05	CbGpPWpGaD
